NO
ELV icon

Ninety One’s Elevance Health ELV Stock Holding History

Ninety One’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.86M Sell
9,865
-6
-0.1% -$2.39K 0.19% 53
2026
Q2 		$3.82M Buy
9,871
+160
+2% +$59.3K 0.21% 54
2026
Q1 		$2.83M Buy
9,711
+453
+5% +$149K 0.12% 56
2025
Q4 		$3.25M Hold
9,258
– – 0.14% 57
2025
Q3 		$2.98M Buy
9,258
+4,322
+88% +$1.34M 0.13% 60
2025
Q2 		$1.92M Sell
4,936
-28
-0.6% -$11.3K 0.32% 52
2025
Q1 		$2.16M Sell
4,964
-710
-13% -$285K 0.4% 49
2024
Q4 		$2.09M Sell
5,674
-11,554
-67% -$4.83M 0.46% 46
2024
Q3 		$8.96M Sell
17,228
-13,789
-44% -$7.37M 1.96% 14
2024
Q2 		$16.8M Sell
31,017
-9,504
-23% -$5.02M 2.6% 11
2024
Q1 		$21M Buy
40,521
+372
+0.9% +$185K 3.03% 8
2023
Q4 		$18.9M Buy
40,149
+7,994
+25% +$3.7M 2.88% 10
2023
Q3 		$14.2M Buy
32,155
+11,398
+55% +$5.17M 2.73% 11
2023
Q2 		$9.17M Buy
20,757
+1,755
+9% +$810K 2.27% 13
2023
Q1 		$8.7M Buy
19,002
+2,389
+14% +$1.14M 2.21% 12
2022
Q4 		$8.48M Sell
16,613
-106
-0.6% -$53.8K 2.75% 8
2022
Q3 		$7.82M Buy
16,719
+13,561
+429% +$6.49M 3.1% 6
2022
Q2 		$1.53M Buy
3,158
+2,367
+299% +$1.17M 0.54% 46
2022
Q1 		$395K Buy
791
+651
+465% +$298K 0.11% 85
2021
Q4 		$65K Sell
140
-6
-4% -$2.52K 0.02% 105
2021
Q3 		$56K Hold
146
– – 0.02% 103
2021
Q2 		$56K Buy
146
+12
+9% +$4.59K 0.02% 105
2021
Q1 		$48K Hold
134
– – 0.02% 107
2020
Q4 		$42K Hold
134
– – 0.02% 110
2020
Q3 		$36K Buy
134
+20
+18% +$5.38K 0.02% 99
2020
Q2 		$29K Hold
114
– – 0.01% 85
2020
Q1 		$26K Buy
+114
New +$31.1K 0.01% 102

Other funds holding ELV

Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
ZWJ Investment Counsel
ZWJ Investment Counsel Atlanta, Georgia $3.24B AUM 31.6% 1-Year Est. Return
Gateway Investment Advisers
Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return
RT
Rockland Trust Hanover, Massachusetts $2.61B AUM 14.26% 1-Year Est. Return
PAS
Professional Advisory Services Vero Beach, Florida $837M AUM 20.44% 1-Year Est. Return
Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
DePrince Race & Zollo Inc (DRZ)
DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.66B AUM 23.19% 1-Year Est. Return

Ninety One's ELV Position: Q3 2026 in Review

Ninety One reduced its Elevance Health (ELV) stake by 0.06% in Q3 2026, selling an estimated $2.39K and leaving 9,865 shares worth $3.86M. The position accounts for 0.19% of the portfolio, ranked #53.

Ninety One first reported a position in ELV in Q1 2020 and has held it in 27 quarters since. The position peaked at $21M in Q1 2024. 161 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Ninety One held 9,865 shares of Elevance Health worth $3.86M as of Q3 2026.
  • Ninety One sold 6 Elevance Health shares in Q3 2026, an estimated $2.39K.
  • Elevance Health made up 0.19% of Ninety One's portfolio in Q3 2026, its #53 holding.
  • Ninety One first reported a position in Elevance Health in Q1 2020 and has held it in 27 quarters since.
  • Ninety One's Elevance Health position peaked at $21M in Q1 2024.
  • 161 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Ninety One's 13F filing for Q3 2026, filed 15 Oct 2026.